FB
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| HCV disease burden and population segments in Switzerland | Liver international |  | 2022 | 155 | 64 | ||
| Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030? | PLOS ONE | | 2018 | 356 | 167 | ||
| Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland | Clinical Reviews in Allergy & Immunology |  | 2017 | 440 | 0 | ||
| Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland | PloS one | | 2015 | 562 | 1 295 | ||
| Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland | Schweizerische medizinische Wochenschrift | | 2015 | 558 | 203 | ||
| Historical epidemiology of hepatitis C virus (HCV) in selected countries | Journal of viral hepatitis | | 2014 | 562 | 1 | ||
| The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm | Journal of viral hepatitis | | 2014 | 549 | 1 | ||
| Survival of hepatocellular carcinoma patients is significantly improving: a population-based study from southern Switzerland | Cancer epidemiology | | 2014 | 569 | 0 | ||
| Strategies to manage hepatitis C virus (HCV) disease burden | Journal of viral hepatitis | | 2014 | 543 | 1 | ||
| Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study | The Journal of infectious diseases | | 2013 | 586 | 0 | ||
| Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection | Journal of viral hepatitis | | 2012 | 596 | 0 | ||
| Anticoagulant therapy for nodular regenerative hyperplasia in a HIV-infected patient | BMC gastroenterology | | 2010 | 962 | 413 | ||
| Hepatic amyloidosis increases liver stiffness measured by transient elastography | Acta gastro-enterologica belgica | | 2010 | 485 | 0 | ||
| Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation | BMC gastroenterology | | 2010 | 633 | 281 | ||
| The new EASL guidelines for the management of chronic hepatitis B infection adapted for Swiss physicians | Schweizerische medizinische Wochenschrift | 2010 | 453 | 0 | |||
| Hepatitis E virus: a zoonosis adapting to humans | The journal of antimicrobial chemotherapy | | 2010 | 485 | 1 | ||
| Acute hepatitis due to brivudin: a case report | Journal of hepatology | | 2009 | 560 | 0 | ||
| Chronic hepatitis E in the immunosuppressed: a new source of trouble? | Journal of hepatology | | 2009 | 528 | 0 | ||
| Vaccination des patients souffrant de maladies chroniques du foie | Revue médicale suisse | | 2007 | 455 | 2 |
